The A-TANGO consortium performs Phase II clinical studies of an innovative therapeutic strategy, called "G-TAK", to fight end-stage cirrhosis and ACLF. Discover the project!

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2024-08-23 DOI:10.1016/S0168-8278(24)02410-3

引用次数: 0

查看原文本刊更多论文

A-TANGO 联盟对一种名为 "G-TAK "的创新治疗策略进行第二阶段临床研究，以对抗终末期肝硬化和 ACLF。了解该项目！

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.